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To the Editor
The American Diabetes Association added a new criterion for the diagnosis of prediabetes, including a glycosylated hemoglobin (HbA 1c ) level of 5.7% to 6.4%, 1 and fasting plasma glucose and glycosylated hemoglobin levels have an advantage for predicting diabetes in the future. 2 I read with interest the article by Bersoux and colleagues 3 reporting that HbA 1c alone cannot identify patients with prediabetes. According to the definition of prediabetes, the predictive ability of prediabetes by HbA 1c is suspected to be low. On this point, Heianza et al 2 recently conducted a follow-up study of 6,241 people (4,670 men and 1,571 women), and 2,092 of them were identified as prediabetic. Among the prediabetic patients, 1,270 (60.7%) were identified by impaired fasting glucose (IFG) alone, 412 patients (19.7%) by HbA 1c alone, and 410 patients (19.6%) by both at baseline study. During a mean 4.7-year follow-up, prediabetes progressed to diabetes in 338 patients. Among them, 292 (86.4%) had been identified as prediabetic at baseline, and the prevalence of prediabetes was categorized as 108 patients (37.0%) identified by IFG alone, 30 (10.3%) by HbA 1c alone, and 154 (52.7%) by both tests. By Cox regression analysis, multivariate hazard ratios of IFG alone, HbA 1c alone, and both tests compared with normoglycemia at baseline were 6.12, 6.00, and 31.9, respectively. I agree that the combination of 2 indicators on prediabetes dramatically improves the predictive ability of diabetes in the near future, partly because fasting plasma glucose and HbA 1c have different meanings on the occurrence of diabetes mellitus. Although oral glucose tolerance testing conducted by Bersoux et al 3 can be set as the "gold standard" to judge type 2 diabetes, their study was classified as a cross-sectional study, which would have difficulty showing a cause-effect relationship. 2 Mann et al 4 reported the prevalence of 3 components (IFG alone, HbA 1c alone, and both factors) in prediabetic patients by using data from the National Health and Nutrition Examination Survey 1999-2006 (n = 7,029; 52% women). Of the patients, 2,590 were identified as prediabetic, and 1,430 patients (55.2%) were identified by IFG alone, 446 (17.2%) by HbA 1c alone, and 714 (27.6%) by both tests. 4 Soloway 5 also pointed out the similarity of these 2 reports. On this point, Bersoux et al 3 reported the prevalence of increased HbA 1c levels in the prediabetes population to be 65.3% (158/242), which is higher than the values found by Mann et al (17.2% + 27.6%). 4 In the Japanese National Health and Nutrition Survey, 5,070 samples for HbA 1c (from 1,986 men and 3,084 women) and 3,741 samples for plasma glucose (1,528 men and 2,213 women) testing were obtained in 2003. 6 More than 30% were identified as IFG, and 38.9% were identified as increased HbA 1c (5.7%-6.4%). Compared with these data, Heianza et al 2 reported a lower prevalence of prediabetic patients examined in a large hospital in Tokyo. The prevalence values of IFG and increased HbA 1c in their study were 26.9% (1,680/6,241) and 13.2% (822/6,241), respectively. 2 When data from the National Health and Nutrition Examination Survey 6 were used, the prevalence values for IFG and increased HbA 1c were 30.5% (2,144/7,029) and 16.5% (1,160/7,029), respectively.
From the viewpoint of prediabetic prevalence, there is doubt about the representativeness of the risk populations in Japanese inhabitants presented by Heianza et al. 2 I speculate that there are ethnic differences in the prevalence of prediabetes, and specification for the target population should strongly be recommended in epidemiologic studies. 
Tomoyuki Kawada, MD

To the Editor
The article by Renshaw 1 expressed the views that nondiagnostic thyroid fine-needle aspiration should be followed by repeat aspiration and that patients with 2 sequential nondiagnostic aspirations have a very low risk of malignancy. We agree with this view. However, the difficulty arises in the case of cystic thyroid lesions.
We are of the view that while doing a repeat aspiration it is better to correlate with ultrasonographic findings and better aspirate from a solid area under guidance. According to Moon et al, 2 shape, margin, echogenicity, and presence of calcification are helpful ultrasound criteria for the discrimination of malignant from benign nodules. A shape that is taller than wide, a spiculated margin, marked hypoechogenicity, and the presence of microcalcifications or macrocalcifications, depending on tumor size, indicate a malignant tumor. On the other hand, benign nodules have isoechogenicity along with a spongiform appearance. Therefore, correlation with ultrasound findings, especially for repeat aspiration, will give more diagnostic information and shall assist in comprehensive reporting.
